Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Head and Neck Neoplasms 3Esophageal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Urologic Neoplasms 1Thoracic Diseases 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Prolactinoma 1Pituitary ACTH Hypersecretion 1Peritoneal Diseases 1Paraproteinemias 1Ovarian Neoplasms 1Ovarian Diseases 1Nervous System Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Mesothelioma, Malignant 1Lymphoma 1Liver Neoplasms 1Leukemia 1Leiomyosarcoma 1Immunoglobulin Light-chain Amyloidosis 1Gigantism 1

Interventions

Tissue Banks 1Clonal Hematopoiesis 1Chromatin Immunoprecipitation Sequencing 1Blood Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Paraproteinemias × Tissue Banks × Clear all
NCT01408225 2026-03-23

B-SCR-MM

Ohio State University Comprehensive Cancer Center

Recruiting
5,000 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡